Medicine
fromBusiness Matters
6 hours agoUK biotech Ternary raises 3.6m to scale AI platform for next-generation drugs
Ternary Therapeutics secured £3.6 million in seed funding to develop an AI-driven platform for engineering molecular glues, a new class of medicines that bring proteins together to destroy disease-causing targets.